Lantheus Holdings names new president, CEO
Lantheus Holdings, the parent company of global imaging manufacturer Lantheus Medical Imaging, announced last week that Mary Anne Heino has been named president and CEO. She is also now one of the company’s directors.
Heino has more than 25 years of experience in the pharmaceutical industry and first joined Lantheus Holdings in 2013.
“Since Mary Anne has joined the Company, she has demonstrated impressive leadership and a deep understanding of our business and industry, first heading our global commercial team and then adding our sophisticated manufacturing and global sourcing operations to her responsibilities,” Brian Markison, Lantheus Holdings chairman of the board, said in a statement. “Mary Anne’s strong commercial and operational skills and strategic vision will be a great asset for us as we focus on continued growth of the company.”
Heino replaces Jeff Bailey, who has served as president, CEO and a director since January 2013.
“I have had the pleasure of working with Mary Anne for many years at both Lantheus and Johnson & Johnson,” Bailey said in the same statement. “She is an excellent leader with a proven track record, and I am proud that she will be taking the reins from here.”
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.